Home/Filings/4/0000950170-24-011248
4//SEC Filing

Barry Douglas 4

Accession 0000950170-24-011248

CIK 0001819133other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:19 PM ET

Size

7.3 KB

Accession

0000950170-24-011248

Insider Transaction Report

Form 4
Period: 2024-02-01
Barry Douglas
General Counsel
Transactions
  • Award

    Common Stock

    2024-02-01+22,85922,859 total
  • Award

    Stock Option (Right to Buy)

    2024-02-01+137,156137,156 total
    Exercise: $12.28Exp: 2034-02-01Common Stock (137,156 underlying)
Footnotes (2)
  • [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 3, 2025, 1/3 on February 2, 2026 and 1/3 on February 1, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
  • [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2025, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Documents

1 file

Issuer

Tango Therapeutics, Inc.

CIK 0001819133

Entity typeother

Related Parties

1
  • filerCIK 0001890662

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:19 PM ET
Size
7.3 KB